Marshall Wace’s cbdMD YCBD Stock Holding History

Marshall Wace’s Portfolio YCBD Stock Details YCBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-46	Closed	-$68K	–	3166
2021 Q1	$68K	Buy	+46	New	+$66.9K	﹤0.01%	2377

Other funds holding YCBD

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LWM

Lionsbridge Wealth Management Jacksonville Beach, Florida $99.5M AUM 25.42% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return

Marshall Wace's YCBD Position: Q2 2021 in Review

Marshall Wace sold out of cbdMD (YCBD) in Q2 2021, closing a stake of 46 shares — an estimated $68K sold.

Marshall Wace first reported a position in YCBD in Q1 2021 and held it in 1 quarter. The position peaked at $68K in Q1 2021. 61 funds tracked by Wall St. Rank hold YCBD as of Q2 2021.

Marshall Wace reported no remaining cbdMD position as of Q2 2021 after selling out during the quarter.
Marshall Wace sold 46 cbdMD shares in Q2 2021, an estimated $68K.
Marshall Wace first reported a position in cbdMD in Q1 2021 and held it in 1 quarter.
Marshall Wace's cbdMD position peaked at $68K in Q1 2021.
61 funds tracked by Wall St. Rank held cbdMD as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.